Proteome Sciences (PRM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.04p
   
  • Change Today:
      0.100p
  • 52 Week High: 4.80
  • 52 Week Low: 2.50
  • Currency: UK Pounds
  • Shares Issued: 295.18m
  • Volume: 621,156
  • Market Cap: £8.97m
  • RiskGrade: 353
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Largest Deals (365 days)

Show trades greater than:

No deals were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

PRM Market Data

Currency UK Pounds
Share Price 3.04p
Change Today 0.100p
% Change 3.40 %
52 Week High 4.80
52 Week Low 2.50
Volume 621,156
Shares Issued 295.18m
Market Cap £8.97m
Beta 0.00
RiskGrade 353

PRM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.78% below the market average11.78% below the market average11.78% below the market average11.78% below the market average11.78% below the market average
65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average
Price Trend
68.26% below the market average68.26% below the market average68.26% below the market average68.26% below the market average68.26% below the market average
52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average
Income Not Available
Growth
2.44% above the market average2.44% above the market average2.44% above the market average2.44% above the market average2.44% above the market average
Sector averageSector averageSector averageSector averageSector average

PRM Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
16:09 125,000 @ 3.39p
15:11 75,000 @ 3.22p
15:10 50,000 @ 3.22p
14:37 130,623 @ 3.22p
14:21 201 @ 3.48p

PRM Key Personnel

CFO Abdelghani Omari

Top of Page